VRILIGY

What is VRILIGY?

The drug VRILIGY is a modern, highly effective pharmacological agent designed to address delicate issues of men's sexual health. This medication belongs to the group of selective serotonin reuptake inhibitors, which are specially adapted to correct the duration of sexual intercourse. The product is available in the form of oral film-coated tablets, which ensures rapid dissolution and optimal bioavailability of the active substance. The pharmaceutical product complies with strict international quality and safety standards, providing a predictable therapeutic effect in most patients.

The main functional purpose of VRILIGY is to improve control over the ejaculation process and prolong the time until its onset in men of reproductive and mature age. Due to the targeted effect on the neurotransmitter systems of the brain, the drug significantly reduces the level of psychological tension associated with the expectation of sexual failure. The effect of the agent is temporary and synaptic, which prevents the occurrence of stable systemic addiction or disruption of the natural hormonal background. The implementation of this pharmacotherapy significantly improves the quality of intimate life and restores confidence in one's own strength.

The production of this medicinal product is carried out by the leading pharmaceutical company Centurion Laboratories, which has established itself as a reliable developer of high-quality generic drugs. The medication belongs to the category of agents for the therapy of urological and andrological disorders, demonstrating a high profile of evidence-based efficacy. Rational use of the product helps to overcome not only the physiological symptoms of the disorder, but also the accompanying psycho-emotional consequences, such as anxiety and depressive states. Regular quality control at each stage of manufacturing guarantees a stable content of the active substance in each unit of product.

What is VRILIGY prescribed for?

The main medical indication for the prescription of this pharmacological agent is premature ejaculation in men aged 18 to 64 years. This condition is characterized by persistent or recurrent onset of ejaculation with minimal sexual stimulation before, during, or immediately after penetration. The use of this medication allows to significantly increase the ejaculation delay, giving a man the opportunity to consciously manage the duration of intimate contact. Thanks to this, harmonization of sexual relations in a couple is achieved and secondary psychological discomfort is relieved.

In addition to the physiological prolongation of sexual intercourse, the medicinal product is indicated for the treatment of pronounced personal distress and social maladaptation caused by rapid ejaculation. Men suffering from this pathology often experience fear of intimacy, which worsens the quality of their personal life. The drug helps to overcome the syndrome of anxious expectation of failure, stabilizing the neurochemical balance in the central nervous system. Systematic or episodic intake of the medication contributes to the restoration of self-esteem and reduces the feeling of dissatisfaction with one's own sexual function.

A therapeutic course using this drug is also prescribed as part of a complex treatment of concomitant erectile disorders, if they are accompanied by accelerated completion of sexual intercourse. In such cases, the agent can be combined with other pharmacological agents under the strict supervision of a urologist or andrologist. It is important to understand that the agent acts purposefully on the mechanisms of ejaculation regulation and is not a libido stimulant or an artificial aphrodisiac. The feasibility of using the drug is established by a specialist based on a detailed analysis of the patient's anamnesis and an assessment of the severity of the existing disorder.

Composition and active components of VRILIGY

The main active substance of this medication is dapoxetine in the form of hydrochloride, which is a specific and potent serotonin reuptake inhibitor. Dapoxetine is rapidly absorbed into the systemic circulation and exerts its pharmacological effect by blocking receptors responsible for the reabsorption of serotonin by neurons. This leads to an increase in the concentration of this neurotransmitter in the synaptic cleft, which enhances impulse transmission in the sympathetic nervous system and delays the ejaculatory reflex. Unlike classical antidepressants, this substance is eliminated from the body as quickly as possible, making it ideal for on-demand use.

In addition to the active component, the composition of each tablet includes carefully selected excipients that ensure the stability of the form and the required rate of disintegration. Among them are microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, and colloidal silicon dioxide. The outer film coating contains hypromellose, titanium dioxide, and special dyes that protect the active substance from the negative effects of moisture and light. All components are pharmaceutically pure, hypoallergenic, and biologically compatible with the human body, which minimizes the risk of developing undesirable local reactions.

The mechanism of action of the active components is based on the modification of the activity of the ejaculatory center located in the spinal cord and brain. Dapoxetine inhibits the passage of nerve impulses from the genitals to the central structures responsible for the onset of orgasm. Due to this, the latent period increases and the duration of reflex contractions of the pelvic floor muscles decreases. The combination of high-purity dapoxetine and high-quality excipients guarantees the high efficacy of VRILIGY without the risk of long-term accumulation of chemical compounds in tissues and organs.

Dosage of VRILIGY

The standard starting dose of the drug for most adult men is 30 milligrams, which should be taken approximately 1–3 hours before the intended sexual intercourse. If the therapeutic effect of this amount proves to be insufficient and side reactions are absent, the doctor may recommend increasing the dosage to the maximum daily limit of 60 milligrams. It is categorically forbidden to exceed the specified dose or take the drug more than once in 24 hours, as this does not enhance the therapeutic effect but significantly increases the risk of developing pharmacological complications. The decision to increase the dose must be made exclusively by a specialist.

The duration of use of this medication is determined individually and depends on the severity of the pathological state and the dynamics of the therapeutic response. The drug is intended for use on demand and does not require mandatory daily course intake over a long period. However, after the first 4 weeks of treatment or after taking at least 6 doses, the doctor must re-evaluate the patient's condition to determine the feasibility of further therapy. In many cases, regular intake helps to build stable psychological confidence, after which the frequency of use can be gradually reduced.

For elderly patients (over 65 years old), the use of this agent is limited due to the lack of a sufficient volume of clinical data on safety. For patients with mild or moderate renal or hepatic impairment, adjustment of the starting dosage is usually not required, but intake should occur with caution. In case of severe liver and kidney dysfunction, the use of this drug is contraindicated. The individual response of the body to the same dose of medicine may differ, so the selection of the optimal regimen always requires a personalized approach.

How to take VRILIGY correctly?

The tablet should be swallowed whole, without chewing, crushing, or breaking it, to prevent premature release of the active substance and a bitter taste in the mouth. The drug must be taken with a sufficient amount of clean drinking water (at least one full glass). This promotes faster passage of the tablet through the gastrointestinal tract and accelerates its absorption into the systemic circulation. The medicine can be taken regardless of food intake, but fatty food may slightly delay the onset of the pharmacological effect.

The time interval between taking this agent and the start of sexual activity should be from 1 to 3 hours to achieve the peak concentration of dapoxetine in blood plasma. Since the agent is intended for on-demand use, the concept of a "missed dose" does not apply to it. If a man forgot to take the tablet in advance, taking it immediately before sexual intercourse will not give an instant result. Never take a double dose of VRILIGY to compensate for the missed time, as this creates an excessive load on the cardiovascular system.

While using the drug, one should refrain from dehydration of the body, especially in hot weather or after intense physical training. In case of dizziness, a pre-fainting state, or rapid heartbeat immediately after taking the medicine, it is necessary to lie down or sit down, lowering the head between the knees. It is not recommended to combine the intake of the medication with the consumption of grapefruit juice, as it can disrupt the metabolism of the active substance in the liver. Compliance with these simple rules will ensure maximum efficacy and safety of the therapeutic process.

Side effects of VRILIGY

Side reactions when using this medication are usually mild or moderate, transient, and quickly pass after the completion of the active substance's action. The most common undesirable effects, observed in more than 10% of patients, include dizziness, headache, and nausea. Also, symptoms such as diarrhea, insomnia, increased fatigue, somnolence, anxiety, hot flashes to the face, and nasal congestion can often occur. Most of these manifestations do not require discontinuation of therapy and disappear on their own as the body adapts to the medicine.

Uncommon and rare side effects include fainting or orthostatic hypotension (a sudden drop in blood pressure when changing body position), tachycardia, mood changes, euphoria, or depressive manifestations. In rare cases, patients may complain of visual impairment (blurred vision, eye pain), tinnitus, increased sweating, taste disorders, and dry mouth. If you notice a pronounced drop in pressure accompanied by loss of consciousness, you should immediately stop using the medicine and seek emergency medical help.

It should be remembered that the individual reaction of the body to dapoxetine is unique for each patient. In case of any atypical or severe symptomatic manifestations that cause concern or do not pass for a long time, it is necessary to consult a doctor. Ignoring the body's signals on your own can lead to complications. The doctor will be able to adjust the dosage or select alternative treatment options, assessing the ratio of benefits and possible risks to your health.

Contraindications of VRILIGY

An absolute contraindication to the use of this medication is individual hypersensitivity or allergic reactions to dapoxetine or any of the excipients of the tablet. The drug is strictly prohibited for patients with severe heart failure (classes II–IV according to NYHA), cardiac conduction disorders (AV block of II-III degree), severe ischemic heart disease, or the presence of an artificial pacemaker. Also, the agent is not prescribed to individuals with severe liver function impairment (classes B and C on the Child-Pugh scale) and severe renal failure.

Agents of this group are contraindicated in patients with manic states, severe depression, or suicidal tendencies in history, as well as in individuals with uncontrolled epilepsy. The medicinal product is categorically not intended for use by women regardless of age, including the period of pregnancy and breastfeeding. The drug is strictly prohibited for use in children, adolescents, and young people under 18 years of age, as the safety and efficacy of its use in this age category have not been studied and are not proven.

Relative contraindications require extreme caution and constant medical supervision during the intake of the medicine. This group includes patients with moderate renal impairment, a history of orthostatic hypotension, increased intraocular pressure (angle-closure glaucoma), or blood clotting disorders. Exceeding the recommended doses in the presence of relative contraindications can provoke exacerbation of chronic diseases. Before starting therapy, be sure to inform your doctor about all existing diagnoses.

Interaction of VRILIGY with other medicines and alcohol

It is categorically forbidden to take the drug simultaneously with monoamine oxidase (MAO) inhibitors, thioridazine, selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and other serotonergic drugs. At least 14 days must pass between the discontinuation of these medications and the start of VRILIGY use. Similarly, after stopping dapoxetine, you should wait at least 7 days before starting to take these agents. Simultaneous use can cause severe, potentially life-threatening reactions, such as serotonin syndrome.

The compatibility of the drug with alcohol is unsatisfactory: the simultaneous consumption of ethanol significantly enhances neurogenic side effects, including dizziness, drowsiness, and slowed reactions. In addition, combination with alcohol increases the risk of syncope (loss of consciousness) and orthostatic hypotension. During therapy with this agent, it is necessary to completely refrain from drinking alcoholic beverages. Given the possible effect of the medicine on the central nervous system, during intake one should refrain from driving vehicles and working with potentially dangerous mechanisms.

Where to buy VRILIGY in Ukraine

The drug VRILIGY can be purchased in most licensed pharmacy chains in Ukraine, as well as ordered through specialized online pharmacy services and certified web platforms. Buying at official points of sale guarantees protection against counterfeits and obtaining a high-quality original product with a proper expiration date. When choosing a supplier, it is recommended to pay attention to the availability of appropriate licenses for pharmaceutical activity. The original drug is supplied in factory packaging with clear labeling and instructions for the patient.

It is necessary to store this medicinal product in its original packaging in a dry, dark place protected from light and out of reach of children at a temperature not exceeding 25–30 degrees Celsius. Do not use the medication after the expiration date printed on the blister and cardboard box. Delivery of online orders is carried out by courier services or national postal operators in accordance with the transport conditions for thermolabile and medical products. Remember that before purchasing and starting to take this agent, a detailed consultation with a doctor is required.